콘텐츠로 건너뛰기
Merck

LC/MS Analysis of Omeprazole and Metabolites in Plasma on Ascentis® Express RP Amide after Sample Prep using HybridSPE®-Phospholipid

LC/MS Analysis of Omeprazole and Metabolites in Plasma on Ascentis® Express RP Amide after Sample Prep using HybridSPE®-Phospholipid application for HPLC, application for SPE

Materials

SPE 튜브 또는 플레이트

제품 번호
설명
가격

HybridSPE®-Phospholipid

96-well Plate, bed wt. 50 mg, volume 2 mL, pk of 1

분석 컬럼

제품 번호
설명
가격

Ascentis® Express RP-Amide, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 5 cm × 2.1 mm

표준

제품 번호
설명
가격

Phenacetin

≥98.0% (HPLC)

Omeprazole sulfone

analytical standard

5-Hydroxyomeprazole

analytical standard

Omeprazole

analytical standard

CONDITIONS

sample preparation

SPE (Solid Phase Extraction)

sample/matrix

rat plasma spiked with omeprazole, phenacetin and metabolites at 2 μg/mL

SPE well plate

HybridSPE-Phospholipid, 96-well plate, 15 mg/0.8 mL (575656-U)

sample addition

100 μL plasma to each well, followed by 300 mL of 1% formic acid in acetonitrile

elution

apply vacuum

eluate post-treatment

eluate was collected, evaporated, and reconstituted in mobile phase.

column

Ascentis Express RP-Amide, 5 cm x 2.1 mm I.D., 2.7 μm particles (53911-U)

mobile phase

[A] water, 10 mM ammonium formate, pH 3.4; [B] methanol, 10 mM ammonium formate, pH 3.4; (65:35, A:B)

flow rate

0.3 mL/min

column temp.

35 °C

detector

ESI(+), m/z = 50-400

injection

1 μL

설명

애플리케이션

This application demonstrates the suitability of HybridSPE and the Ascentis Express RP Amide for the analysis of omeprazole metabolites.

분석 메모

Sample was vorlexed and centrifuged for 2 minutes at 15000 rpm. Supemate was then passed through HybridSPE 96 well plate. Elutent was collected, evaporated and reconstituted in mobile phase.

법적 정보

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
HybridSPE is a registered trademark of Merck KGaA, Darmstadt, Germany